companies

ELEM Biotech

Founded 2018
Employees 10+
Primary contact
Pier01 - Palau de Mar - Plaça Pau Vila, 1
Bloc A, Planta 3, Porta 3A1
08003 Barcelona
Catalonia
Spain
+34 93 834 2660
Links
https://elem.bio/
Diseases & Conditions
Sections
Technologies
ELEM Biotech is developing a Virtual Human technology that it hopes to become the standard for medical testing and in-silico clinical trials. More specifically, the company is creating cutting-edge supercomputer-based patient modeling and simulation solutions, deployed in the cloud, that help MedTech and Pharma companies, and CROs optimize their products and offer new evidence to clinicians to personalize treatments. At the moment, the company offers virtual cardiovascular and respiratory systems, with the idea to virtualize a completely interconnected network of organs and systems. ELEM is a spin-off from the Barcelona Supercomputing Center.
Select partners: Oracle, Medical Alley Association, Spanish National Research Council (CSIC), Avicenna Alliance, SETsquared Bristol, Barcelona Supercomputing Center.
Founded 2018
Employees 10+
Primary contact
Pier01 - Palau de Mar - Plaça Pau Vila, 1
Bloc A, Planta 3, Porta 3A1
08003 Barcelona
Catalonia
Spain
+34 93 834 2660
Links
https://elem.bio/
Diseases & Conditions
Sections
Technologies

Funding 💰

Total $1.37M
Select investors Genesis Biomed, Iberdrola, Oracle Startup Cloud Accelerator, Capital Cell, Namarel Ventures

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Improving clinical trials: The National Institute of Health (NIH) has calculated that when a drug fails, once it reaches Phase III, the losses for the company reach billions of dollars. ELEM's solution helps with that while also reducing animal testing by reaching clinical trial endpoints earlier in the development process. 🔗
  • Brain power: ELEM is a spin-off from Barcelona Supercomputing Center and it has a multi-disciplinary team, integrating disciplines from engineering to mathematics, physics, biology, medicine, and computer science.
  • Years in the making: ELEM's technology is a result of 14 years of work, 100 papers published, more than 400 million core hours of supercomputing power spent, and 5 million euros invested in development. 🔗
  • Media love: The information about ELEM Biotech's virtual heart has been featured in Forbes. 🔗

Video ▶️

Awards & Recognitions 🏆

  • 2021 European Commission's Seal Of Excellence
  • 2019 Launch Great West: Finalist 🔗
Last update: August 17, 2022